Timely perspectives on the trends, risks, and decisions shaping multilingual life sciences content.
Explore where AI-assisted clinical translation can introduce quality, oversight, and compliance risks, and why expert human review still matters for regulated multilingual content.
Read insightPerspective-led coverage of submission content, multilingual controls, and readiness considerations across global markets.
Analysis of where AI can support speed, consistency, and scale while maintaining the right level of expert oversight.
Thoughtful discussion of terminology governance, review expectations, and quality decisions that shape regulated content programs.
Read Sesen perspectives on multilingual content strategy, translation quality, regulatory expectations, AI-enabled workflows, and global communication for life sciences teams.
Explore where AI-assisted translation and MTPE can support speed and scale, and where higher-risk life sciences content still demands stronger human oversight.
Read insightReview multilingual risks that affect submission quality, terminology consistency, and regulatory readiness across global markets.
Read insightSee what sponsors and CROs should evaluate when selecting a translation partner for multilingual trial documentation and patient communication.
Read insightLearn how terminology, formatting, and localization gaps can affect submission outcomes and downstream regulatory communication.
Read insightCompare multilingual submission considerations across major health authorities and understand how localization choices affect global regulatory strategy.
Read insightA look at major shifts shaping medical translation strategy, from AI adoption and workflow design to quality expectations in regulated content.
Read insightFind expert perspectives by content type, workflow challenge, regulatory need, or translation strategy.
Insights on ICFs, protocols, patient-facing materials, site documents, eCOA, ePRO, recruitment content, and global study communication.
Explore topicPerspectives on submissions, agency-facing content, labeling updates, safety documentation, and multilingual regulatory readiness.
Explore topicAnalysis of AI-assisted translation, MTPE, SesenGPT workflows, AI QA, terminology intelligence, human review, and validation controls.
Explore topicInsights on IFUs, labeling, software localization, technical documentation, UDI-related content, and global device market readiness.
Explore topicCommentary on drug development content, medical affairs, labeling, launch communication, scientific content, and lifecycle updates.
Explore topicPerspectives on readability, cultural adaptation, health literacy, patient education, disease awareness, and multilingual engagement.
Explore topicInsights on glossaries, style guides, translation memory, reviewer feedback, quality checks, and content consistency.
Explore topicAnalysis of multilingual operations, content reuse, global market entry, localization planning, and enterprise translation programs.
Explore topicSesen Blog & Insights focuses on the strategic, operational, and technology trends affecting multilingual life sciences communication.
Industry shifts, regulatory expectations, AI adoption, global operating models, and multilingual content transformation.
Commentary on clinical, regulatory, labeling, safety, medical device, and patient-facing translation challenges.
Practical analysis of how AI can support translation speed, terminology consistency, QA, and workflow orchestration while preserving expert accountability.
Insights for sponsors, CROs, medical device companies, pharmaceutical teams, biotech organizations, and healthcare technology companies managing multilingual content at scale.
Start with high-value perspectives selected for clinical, regulatory, AI, and global content teams.
A focused look at where risk, oversight, terminology control, and human review matter most in multilingual trial content.
Read insightGuidance for managing multilingual trial materials across study start-up, patient communication, and global execution.
Read insightExplore how submission structure, consistency, and terminology alignment affect multilingual regulatory document readiness.
Read insightSee what matters most for readability, clarity, cultural fit, and multilingual consistency in informed consent communication.
Read insightLearn how terminology structure and review discipline support consistency across regulated multilingual content programs.
Read insightA practical perspective on why expert human review remains essential when AI-assisted translation is used for clinical, regulatory, labeling, safety, medical device, and patient-facing life sciences content.
Read insightExplore perspectives by the role, team, or organization responsible for multilingual content quality and global communication.
Clinical trial documentation, site materials, recruitment content, ICFs, patient communication, and multilingual study support.
Submissions, labeling updates, agency communication, safety documentation, and country-specific content requirements.
IFUs, labeling, technical documentation, software strings, product updates, and post-market communication.
Scientific content, HCP education, patient education, disease awareness, launch materials, and global brand consistency.
Translation memory, terminology, workflow design, vendor governance, AI adoption, cost control, and enterprise scalability.
Continue from strategic insights into practical guidance, case studies, technical resources, and operational tools.
Sesen helps life sciences teams manage clinical, regulatory, labeling, medical device, AI-assisted, and patient-facing translation workflows across global markets. Talk with Team Sesen about your content priorities, quality requirements, and multilingual operating model.
